| Outcome Measures: |
Primary: Combined categorized endpoint, Percentage of patients achieving the following composite endpoint in the two groups: reduction of HbA1c ≥0.5% and reduction of body weight ≥2 kg and reduction of systolic blood pressure ≥2 mmHg., 3-12 months | Secondary: Combined endpoint, Percentage of patients achieving the following composite endpoint in the two groups: any reduction of HbA1c and any reduction of body weight and any reduction of systolic blood pressure., 3-12 months|Change in HbA1c, Average change in HbA1c (%) from baseline to end of follow-uo, 3-12 months|Change in body weight, Average change in body weight (kg) from baseline to end of follow-uo, 3-12 months|Change in systolic blood pressure, Average change in systolic blood pressure (mm Hg) from baseline to end of follow-uo, 3-12 months|Proportion of patients attaining HbA1c target, Proportion of patients experiencing a reduction of 0.5% or more in HbA1c from baseline to follow-up, 3-12 months|Proportion of patients attaining body weight target, Proportion of patients experiencing a reduction of 2 kg or more in body weight from baseline to follow-up, 3-12 months|Proportion of patients attaining blood pressure target, Proportion of patients experiencing a reduction of 2 mm Hg or more in systolic blood pressure from baseline to follow-up, 3-12 months
|
